Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › DarwinHealth Precision Cancer Tests Licensed by Encheng Group in China

DarwinHealth Precision Cancer Tests Licensed by Encheng Group in China

Dec 19, 2018
|
staff reporter

NEW YORK (GenomeWeb) — The Encheng Group said today that it has signed an agreement to acquire the exclusive commercial rights to DarwinHealth's precision cancer medicine tests in the Greater China region, which includes Hong Kong, Macao, and Taiwan.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
14
Featured Webinar

Development of a Metagenomics-based Pathogen-Detection Assay for SARS-CoV-2 Research

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

What's Popular?

In Molecular Diagnostics

  1. FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test

  2. Amid Interest Generated by Coronavirus Testing, IPO Window Open for Dx Firms in 2020

    Premium

  3. FDA Issues New Guidance for SARS-CoV-2 Pooled Sample Testing

  4. FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests

  5. SARS-CoV-2 Pandemic May Promote Progress in Paper MDx

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.